DCC | ECC | Relative risk (95% CI) / Mean difference (95% CI) | p value | ||||
---|---|---|---|---|---|---|---|
Primary outcome | |||||||
Spectrophotometric hemoglobin (SpHb) at 4 months | |||||||
(n = 127/DCC = 65,ECC = 62) | 12.4 | (0.8) | 12.3 | (0.7) | 0.1 | [−0.17, 0.35] | 0.50 |
Secondary outcome | |||||||
Anemia (SpHb < 11.0 g/dl) (n = 126/DCC = 64,ECC = 62) | 1 | (1.6) | 0 | (0.0) | 1.0 | [0.95, 1.02] | 1.00 |
Neonatal jaundice | |||||||
Total serum bilirubin (TsB) (days 3-5)) a (n = 122/DCC = 63, ECC = 59) | 12.8 | (3.5) | 12.1 | (3.4) | 0.7 | [−0.55, 1.91] | 0.27 |
Over the excess level of transcutaneous bilirubin (TsB) b (n = 122/DCC = 63, ECC = 59) | 6 | (9.5) | 4 | (6.8) | 1.4 | [0.42, 4.73] | 0.75 |
Phototherapy c (n = 123/DCC = 63, ECC = 60) | 7 | (11.1) | 4 | (6.7) | 1.7 | [0.51, 5.40] | 0.53 |
Hematocrit | |||||||
Hematocrit level (days 3-5) (%) a (n = 121/DCC = 62, ECC = 59) | 57.2 | (5.3) | 52.5 | (5.2) | 4.6 | [2.74, 6.53] | < 0.01* |
High hematocrit (Hct≧65%) (n = 121/DCC = 62, ECC = 59) | 3 | (4.6) | 2 | (3.0) | 0.7 | [0.10, 4.00] | 0.68 |